Comparison of Power, Prognosis, and Extrapolation Properties of Four Population Pharmacodynamic Models of HbA1c for Type 2 Diabetes-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Comparison of Power, Prognosis, and Extrapolation Properties of Four Population Pharmacodynamic Models of HbA1c for Type 2 Diabetes

Published:2018-03-25 Issue:5 Volume:7 Page:331-341
ISSN:2163-8306
Container-title:CPT: Pharmacometrics & Systems Pharmacology
language:en
Short-container-title:CPT Pharmacometrics Syst. Pharmacol.

Author:

Wellhagen Gustaf J.¹,Karlsson Mats O.¹,Kjellsson Maria C.¹

Affiliation:

1. Department of Pharmaceutical Biosciences; Uppsala University; Uppsala Sweden

Funder

Innovative Medicines Initiative Joint Undertaking

European Union Seventh Framework Programme

European Federation of Pharmaceutical Industries and Associations

IDeAl Project

Publisher

Wiley

Subject

Pharmacology (medical),Modelling and Simulation

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/psp4.12290/fullpdf

Reference34 articles.

1. The impact of mathematical modeling on the understanding of diabetes and related complications;Ajmera;CPT Pharmacometrics Syst. Pharmacol.,2013

2. Dose selection using a semi-mechanistic integrated glucose-insulin-glucagon model: designing phase 2 trials for a novel oral glucokinase activator;Zhang;J. Pharmacokinet. Pharmacodyn.,2013

3. Population pharmacokinetics and pharmacodynamics of IONIS-GCGRRx, an antisense oligonucleotide for type 2 diabetes mellitus: a red blood cell lifespan model;Luu;J. Pharmacokinet. Pharmacodyn.,2017

4. Models for plasma glucose, HbA1c, and hemoglobin interrelationships in patients with type 2 diabetes following tesaglitazar treatment;Hamrén;Clin. Pharmacol. Ther.,2008

5. Impact of demographics and disease progression on the relationship between glucose and HbA1c;Claussen;Eur. J. Pharm. Sci.,2017

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research Progress of Population Pharmacokinetic of Metformin;BioMed Research International;2022-12-19

2. Optimization of trial duration to predict long‐term HbA1c change with therapy: A pharmacometrics simulation‐based evaluation;CPT: Pharmacometrics & Systems Pharmacology;2022-09-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3